Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ullgren, A."'
Autor:
Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden., Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden., Olofsson J; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Bergström S; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Remnestål J; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands., Jiskoot LC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands., Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands., Borroni B; Department of Clinical and Experimental Sciences, Centre for Neurodegenerative Disorders, University of Brescia, Brescia, Italy., Sanchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain., Moreno F; Department of Neurology, Cognitive Disorders Unit, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain., Laforce R; Département Des Sciences Neurologiques, Clinique Interdisciplinaire de Mémoire, CHU de Québec, and Faculté de Médecine, Université Laval, Quebec City, QC, Canada., Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Galimberti D; Fondazione IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada., Tartaglia MC; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada., Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada., Vandenberghe R; Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium., de Mendonça A; Faculty of Medicine, University of Lisbon, Lisbon, Portugal., Tirabosch P; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy., Santana I; Faculty of Medicine, University Hospital of Coimbra (HUC), Neurology Service, University of Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Ducharme S; Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Québec, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada., Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK., Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen, Essen, Germany., Otto M; Department of Neurology, University of Ulm, Ulm, Germany., Bouzigues A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Russell L; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Swift IJ; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Heller C; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK.; Dementia Research Institute at UCL, UCL Queen Square Institute of Neurology, London, UK., Månberg A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Nilsson P; Swedish FTD Initiative, Stockholm, Sweden.; Department of Protein Science, Division of Affinity Proteomics, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden., Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2023 Nov 15; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2023 Nov 15.
Autor:
Khoshnood B; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. behzad.khoshnood@ki.se.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden. behzad.khoshnood@ki.se.; Swedish FTD Initiative, Stockholm, Sweden. behzad.khoshnood@ki.se., Ullgren A; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Laffita-Mesa J; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Öijerstedt L; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Patra K; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Nennesmo I; Department of Pathology, Karolinska University Hospital, Stockholm, Sweden., Graff C; Division for Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Karolinska University Hospital Solna, Stockholm, Sweden. caroline.graff@ki.se.; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.
Publikováno v:
Journal of neurology [J Neurol] 2022 Jun; Vol. 269 (6), pp. 3037-3049. Date of Electronic Publication: 2021 Nov 20.
Autor:
Bergström S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden., Remnestål J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden., Seelaar H; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands., van Swieten JC; Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands., Synofzik M; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.; Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany., Sanchez-Valle R; Alzheimer's disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain., Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain., Finger E; Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada., Masellis M; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada., Tartaglia C; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada., Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospitals Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium., Laforce R; Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, QC, Canada., Galimberti D; Fondazione IRCCS Ospedale Policlinico, Milan, Italy.; University of Milan, Centro Dino Ferrari, Milan, Italy., Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Butler CR; Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.; Department of Brain Sciences, Imperial College London, London, UK., Gerhard A; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg- Essen, Duisburg, Germany., Ducharme S; Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Québec, Canada.; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada., Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, UK., Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Unit of Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se.; Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden. caroline.graff@ki.se., Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden. peter.nilsson@scilifelab.se.; Swedish FTD Initiative, Stockholm, Sweden. peter.nilsson@scilifelab.se.
Publikováno v:
Molecular neurodegeneration [Mol Neurodegener] 2021 Nov 27; Vol. 16 (1), pp. 79. Date of Electronic Publication: 2021 Nov 27.
Autor:
Remnestål J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Öijerstedt L; Swedish FTD Initiative, Stockholm, Sweden.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden.; Unit for hereditary dementias, Theme Aging, Karolinska University Hospital, Stockholm, Sweden., Ullgren A; Swedish FTD Initiative, Stockholm, Sweden.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden., Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Bergström S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Kultima K; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden., Ingelsson M; Department of Public Health and Caring Sciences, Geriatrics, Uppsala University, Uppsala, Sweden., Kilander L; Department of Public Health and Caring Sciences, Geriatrics, Uppsala University, Uppsala, Sweden., Uhlén M; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Department of Neuroscience, Karolinska Institutet, Solna, Sweden., Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden.; Swedish FTD Initiative, Stockholm, Sweden., Graff C; Swedish FTD Initiative, Stockholm, Sweden. caroline.graff@ki.se.; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 64, Solna, Sweden. caroline.graff@ki.se.; Unit for hereditary dementias, Theme Aging, Karolinska University Hospital, Stockholm, Sweden. caroline.graff@ki.se., Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Tomtebodavägen 23 A, Alpha 2, 171 65 Solna, Stockholm, Sweden. peter.nilsson@scilifelab.se.; Swedish FTD Initiative, Stockholm, Sweden. peter.nilsson@scilifelab.se.
Publikováno v:
Translational neurodegeneration [Transl Neurodegener] 2020 Jun 23; Vol. 9 (1), pp. 27. Date of Electronic Publication: 2020 Jun 23.
Autor:
Abbe Ullgren, Linn Öijerstedt, Jennie Olofsson, Sofia Bergström, Julia Remnestål, John C. van Swieten, Lize C. Jiskoot, Harro Seelaar, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Matthis Synofzik, Daniela Galimberti, James B. Rowe, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonça, Pietro Tirabosch, Isabel Santana, Simon Ducharme, Chris R. Butler, Alexander Gerhard, Markus Otto, Arabella Bouzigues, Lucy Russell, Imogen J. Swift, Aitana Sogorb-Esteve, Carolin Heller, Jonathan D. Rohrer, Anna Månberg, Peter Nilsson, Caroline Graff, on behalf of the Genetic Frontotemporal Dementia Initiative (GENFI)
Publikováno v:
Molecular Neurodegeneration, Vol 18, Iss 1, Pp 1-12 (2023)
Abstract Background Plasma biomarkers reflecting the pathology of frontotemporal dementia would add significant value to clinical practice, to the design and implementation of treatment trials as well as our understanding of disease mechanisms. The a
Externí odkaz:
https://doaj.org/article/07eda451536c4719977177dd2e2955fe
Autor:
Julia Remnestål, Linn Öijerstedt, Abbe Ullgren, Jennie Olofsson, Sofia Bergström, Kim Kultima, Martin Ingelsson, Lena Kilander, Mathias Uhlén, Anna Månberg, Caroline Graff, Peter Nilsson
Publikováno v:
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-13 (2020)
Abstract Background The clinical presentations of frontotemporal dementia (FTD) are diverse and overlap with other neurological disorders. There are, as of today, no biomarkers in clinical practice for diagnosing the disorders. Here, we aimed to find
Externí odkaz:
https://doaj.org/article/988f149e5a724fe5a959b7c6f82c94f9
Autor:
Pérez-Millan, Agnès, Borrego-Écija, Sergi, van Swieten, John C., Jiskoot, Lize, Moreno, Fermin, Laforce, Robert, Graff, Caroline, Masellis, Mario, Tartaglia, Maria Carmela, Rowe, James B., Borroni, Barbara, Finger, Elizabeth, Synofzik, Matthis, Galimberti, Daniela, Vandenberghe, Rik, de Mendonça, Alexandre, Butler, Chris R., Gerhard, Alexander, Ducharme, Simon, Le Ber, Isabelle, Santana, Isabel, Pasquier, Florence, Levin, Johannes, Otto, Markus, Sorbi, Sandro, Tiraboschi, Pietro, Seelaar, Harro, Langheinrich, Tobias, Rohrer, Jonathan D., Sala-Llonch, Roser, Sánchez-Valle, Raquel, GENFI The Genetic FTD Initiative, Ullgren, Abbe, Rollin, Adeline, Camuzat, Agnès, Esteve, Aitana Sogorb, Gabilondo, Alazne, Lladó, Albert, Benussi, Alberto, Brice, Alexis, Gorostidi, Ana, Verdelho, Ana, Arighi, Andrea, Antonell, Anna, Bertrand, Anne, Engel, Annerose, Vogels, Annick, Bouzigues, Arabella, Funkiewiez, Aurélie, Nacmias, Benedetta, Bender, Benjamin, Ferrari, Camilla, Wilke, Carlo, Heller, Carolin, Maruta, Carolina, Greaves, Caroline V., Timberlake, Carolyn, Ferreira, Catarina B., Prix, Catharina, Fenoglio, Chiara, Shoesmith, Christen, Polito, Cristina, Rinaldi, Daisy, Saracino, Dario, Cash, David, Thomas, David L., Tang-Wai, David, Duro, Diana, Rogaeva, Ekaterina, Scarpini, Elio, Wlasich, Elisabeth, Buratti, Emanuele, Todd, Emily, Premi, Enrico, do Couto, Frederico Simões, Miltenberger, Gabriel, Lombardi, Gemma, Rossi, Giacomina, Fumagalli, Giorgio, Giaccone, Giorgio, Di Fede, Giuseppe, Kuchcinski, Gregory, Benotmane, Hanya, Zetterberg, Henrik, Swift, Imogen J., Poos, Jackie, M. Papma, Janne, Nicholas, Jennifer, Durães, João, Lombardi, Jolina, Juncà-Parella, Jordi, Sarto, Jordi, Villanua, Jorge, Samra, Kiran, Poesen, Koen, Öijerstedt, Linn, Graf, Lisa, Giannini, Lucia, Russell, Lucy L., Leitão, Maria João, Almeida, Maria Rosario, Serpente, Maria, Lima, Marisa, Cañada, Marta, Bocchetta, Martina, Polyakova, Maryna, Vandenbulcke, Mathieu, Bertoux, Maxime, Veldsman, Michele, Castelo-Branco, Miguel, Tábuas-Pereira, Miguel, Tainta, Mikel, Balasa, Mircea, Zulaica, Miren, Freedman, Morris, Barandiaran, Myriam, Bargalló, Nuria, Wagemann, Olivia, Colliot, Olivier, Caroppo, Paola, Alves, Patricia, Thompson, Paul, Rosa-Neto, Pedro, Van Damme, Philip, Shafei, Rachelle, Convery, Rhian S., van Minkelen, Rick, Bartha, Robart, Gasparotti, Roberto, Keren, Ron, Rademakers, Rosa, Bruffaerts, Rose, Sayah, Sabrina, Black, Sandra, Loosli, Sandra, Mitchell, Sara, Prioni, Sara, Anderl-Straub, Sarah, Gauthier, Serge, Afonso, Sónia, Schönecker, Sonja, Gazzina, Stefano, Lebouvier, Thibaud, Cope, Thomas, Rittman, Timothy, Hoegen, Tobias, Bessi, Valentina, Cantoni, Valentina, Redaelli, Veronica, Jelic, Vesna, Deramecourt, Vincent, Borracci, Vittoria
Publikováno v:
Journal of neurology
Journal of neurology 270(3), 1573-1586 (2022). doi:10.1007/s00415-022-11435-x
Journal of neurology 270(3), 1573-1586 (2022). doi:10.1007/s00415-022-11435-x
Background and objectives The C9orf72 expansion is the most common genetic cause of frontotemporal dementia (FTD) and/or motor neuron disease (MND). Corticospinal degeneration has been described in post-mortem neuropathological studies in these patie
Autor:
José Miguel Laffita-Mesa, Abbe Ullgren, Inger Nennesmo, Kalicharan Patra, Linn Öijerstedt, Behzad Khoshnood, Caroline Graff
Publikováno v:
Journal of Neurology. 269:3037-3049
Background Frontotemporal dementia (FTD) is a neurodegenerative disease, resulting in progressive problems in language and/or behaviour and is often diagnosed before 65 years of age. Ubiquitin positive protein aggregates in the brain are among the ke
Autor:
Yolande A.L. Pijnenburg, Alessandro Padovani, Lieke H.H. Meeter, Rita Guerreiro, Mathieu Vandenbulcke, Rose Bruffaerts, Sonja Schönecker, Sofia Bergström, Florence Pasquier, Mikel Tainta, Beatriz Santiago, Roberto Gasparotti, Maria Rosário Almeida, Núria Bargalló, Abbe Ullgren, Martina Bocchetta, James B. Rowe, Pietro Tiraboschi, Robart Bartha, Rachelle Shafei, Benjamin Bender, Anna Månberg, Enrico Premi, Sergi Borrego-Écija, Sandro Sorbi, Christopher C Butler, Rick van Minkelen, Alberto Benussi, Marta Cañada, Carlo Wilke, Christin Andersson, Caroline Graff, Isabel Santana, Elisa Semler, Valentina Bessi, Miren Zulaica, Benedetta Nacmias, Tobias Langheinrich, Christen Shoesmith, Philip Van Damme, Camilla Ferrari, Martin Rosser, Pedro Rosa-Neto, Alexandre de Mendonça, Jennifer M. Nicholas, Catharina Prix, Sebastien Ourselin, Michele Veldsman, Jessica L. Panman, Håkan Thonberg, Jennie Olofsson, Paul M. Thompson, Ana Gorostidi, Andrea Arighi, Raquel Sánchez-Valle, Anna Antonell, Vesna Jelic, Ana Verdelho, Sara Mitchell, Janne M. Papma, Alina Díez, Giuliano Binetti, Rhian S Convery, Silvana Archetti, Ekaterina Rogaeva, Michela Pievani, C. Ferreira, Hans-Otto Karnath, Veronica Redaelli, Giuseppe Di Fede, Giovanni B. Frisoni, Carolina Maruta, Giacomina Rossi, Jaume Olives, Simon Ducharme, Roberta Ghidoni, Alexander Gerhard, Ron Keren, Johannes Levin, Sandra V. Loosli, Jose Bras, Isabelle Le Ber, Emily Todd, Robert Laforce, Sónia Afonso, Matthis Synofzik, Alazne Gabilondo, Elizabeth Finger, Thomas E. Cope, Paola Caroppo, Jorge Villanua, Diana Duro, Georgia Peakman, Giorgio G. Fumagalli, Serge Gauthier, Mario Masellis, Markus Otto, Caroline V. Greaves, Carolyn Timberlake, Harro Seelaar, Ione O.C. Woollacott, Sara Prioni, Jason D. Warren, Cristina Polito, Miguel Tábuas-Pereira, David F. Tang-Wai, Carmela Tartaglia, Linn Öijerstedt, Luisa Benussi, Barbara Borroni, Ricardo Taipa, Albert Lladó, Mircea Balasa, Rosa Rademakers, Lize C. Jiskoot, Miguel Castelo-Branco, Julia Remnestål, Fabrizio Tagliavini, Giorgio Giaccone, Maria João Leitão, Henrik Zetterberg, Valentina Cantoni, Daniela Galimberti, Sarah Anderl-Straub, Simon Mead, Myriam Barandiaran, Adrian Danek, Timothy Rittman, Chiara Fenoglio, Katrina M. Moore, David M. Cash, Rik Vandenberghe, Peter Nilsson, Elisabeth Wlasich, John C. van Swieten, Morris Freedman, Sandra E. Black, Carolin Heller, Stefano Gazzina, Gabriel Miltenberger, Fermin Moreno, Nick C. Fox, David L. Thomas, Jonathan D. Rohrer, Begoña Indakoetxea, Tobias Hoegen, Gemma Lombardi, Elio Scarpini
Publikováno v:
MOLECULAR NEURODEGENERATION, 16(1):79. BioMed Central
Molecular Neurodegeneration
Molecular Neurodegeneration, Vol 16, Iss 1, Pp 1-14 (2021)
Molecular Neurodegeneration, 16(1):79. BioMed Central Ltd.
Molecular neurodegeneration 16(1), 79 (2021). doi:10.1186/s13024-021-00499-4
on behalf of the Genetic Frontotemporal Dementia Initiative (GENFI) 2021, ' A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers : a GENFI study ', MOLECULAR NEURODEGENERATION, vol. 16, no. 1, 79 . https://doi.org/10.1186/s13024-021-00499-4
Molecular Neurodegeneration
Molecular Neurodegeneration, Vol 16, Iss 1, Pp 1-14 (2021)
Molecular Neurodegeneration, 16(1):79. BioMed Central Ltd.
Molecular neurodegeneration 16(1), 79 (2021). doi:10.1186/s13024-021-00499-4
on behalf of the Genetic Frontotemporal Dementia Initiative (GENFI) 2021, ' A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers : a GENFI study ', MOLECULAR NEURODEGENERATION, vol. 16, no. 1, 79 . https://doi.org/10.1186/s13024-021-00499-4
Availability of data and materials: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Supplementary Information: Additional file 1 of A panel of CSF proteins separates geneti
Autor:
Behzad, Khoshnood, Abbe, Ullgren, Jose, Laffita-Mesa, Linn, Öijerstedt, Kalicharan, Patra, Inger, Nennesmo, Caroline, Graff
Publikováno v:
Journal of neurology. 269(6)
Frontotemporal dementia (FTD) is a neurodegenerative disease, resulting in progressive problems in language and/or behaviour and is often diagnosed before 65 years of age. Ubiquitin positive protein aggregates in the brain are among the key pathologi